Company news
Shanghai Allist Pharmaceuticals Co. Ltd. Class A (SSE:688578) news
Shanghai Allist Pharmaceuticals Co. Ltd. Class A news releases on 6ix. Latest, May 25, 2024: Announcement on Implementation of Dividend Distribution for 2023
Press releases — page 2
Announcement on Implementation of Dividend Distribution for 2023
May 24, 2024
Announcement on Resolutions of 2023 Annual General Meeting
May 16, 2024
Special Report on Storage and Actual Use of Raised Funds in 2023
April 25, 2024
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of AST2169 Liposome for Injection
March 13, 2024
Announcement on 2023 Annual Preliminary Earnings Estimate
February 23, 2024
2023 Annual Performance Forecast
January 29, 2024
Announcement on Voluntary Disclosure of Publicity of Furmonertinib Mesilate Tablets for First-line Indication Treatment of EGFR20 Exon Insertion Mutated NSCLC Included in Potential Breakthrough Therapy Variety
January 8, 2024
Announcement on Resolution of 6th Session of 2nd Board of Supervisors
December 15, 2023